- Home
- ALVO vs PTY Comparison
ALVO vs PTY Comparison
Compare ALVO & PTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVO
- PTY
- Stock Information
- Founded
- ALVO 2013
- PTY 2002
- Country
- ALVO Luxembourg
- PTY United States
- Employees
- ALVO N/A
- PTY N/A
- Industry
- ALVO Biotechnology: Pharmaceutical Preparations
- PTY Investment Managers
- Sector
- ALVO Health Care
- PTY Finance
- Exchange
- ALVO Nasdaq
- PTY Nasdaq
- Market Cap
- ALVO 2.5B
- PTY 2.6B
- IPO Year
- ALVO N/A
- PTY N/A
- Fundamental
- Price
- ALVO $9.61
- PTY $13.85
- Analyst Decision
- ALVO Buy
- PTY
- Analyst Count
- ALVO 1
- PTY 0
- Target Price
- ALVO $18.00
- PTY N/A
- AVG Volume (30 Days)
- ALVO 314.4K
- PTY 550.4K
- Earning Date
- ALVO 08-14-2025
- PTY 01-01-0001
- Dividend Yield
- ALVO N/A
- PTY 9.65%
- EPS Growth
- ALVO N/A
- PTY N/A
- EPS
- ALVO 0.34
- PTY N/A
- Revenue
- ALVO $587,890,000.00
- PTY N/A
- Revenue This Year
- ALVO $36.18
- PTY N/A
- Revenue Next Year
- ALVO $42.61
- PTY N/A
- P/E Ratio
- ALVO $28.20
- PTY N/A
- Revenue Growth
- ALVO 413.92
- PTY N/A
- 52 Week Low
- ALVO $7.35
- PTY $11.92
- 52 Week High
- ALVO $13.70
- PTY $14.88
- Technical
- Relative Strength Index (RSI)
- ALVO 59.59
- PTY 56.35
- Support Level
- ALVO $8.51
- PTY $13.73
- Resistance Level
- ALVO $8.91
- PTY $13.87
- Average True Range (ATR)
- ALVO 0.36
- PTY 0.07
- MACD
- ALVO 0.13
- PTY -0.00
- Stochastic Oscillator
- ALVO 99.22
- PTY 54.55
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
About PTY Pimco Corporate & Income Opportunity Fund
PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.